Advertisement

NMR-Spektroskopie bei kardiovaskulären Erkrankungen — ein Überblick

  • W. Heindel
  • H. Kugel
Conference paper

Zusammenfassung

Die Kernspinresonanz [NMR („nuclear magnetic resonance“)] wird in der Medizin vor allem als bildgebendes Verfahren zur Darstellung der Gewebsmorphologie eingesetzt. Bei geschickter Wahl der Meßparameter sind dabei, z.B. in der MR-Angiographie, auch Funktionsdarstellungen möglich.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Ackerman JJH, Grove TH, Wong GC, et al (1980) Mapping of metabolites in whole animals by 31P-NMR using surface coils. Nature 287:167–170CrossRefGoogle Scholar
  2. 2.
    Aue WP, Müller S, Cross TA, Seelig J (1984) Volume selective excitation. A novel approach to topical NMR. J Magn Reson 56:350Google Scholar
  3. 3.
    Auffermann W, Chew W, Tavares NJ, et al (1989) P-31 MR spectroscopy and cine MR imaging in patients with dilated cardiomyopathy. In: Book of Abstracts: Society of Magnetic Resonance in Medicine 1989, vol 1. Society of Magnetic Resonance in Medicine, Berkeley CA, p 37Google Scholar
  4. 4.
    Blackledge MJ, Rajagopalan B, Oberhaensli RD, et al (1986) Quantitative studies of human cardiac metabolism by P-31 rotating frame NMR. Proc Natl Acad Sci USA 84:4283–4287CrossRefGoogle Scholar
  5. 5.
    Bottomley PA (1985) Noninvasive study of high energy metabolism in human heart by depth-resolved 31P NMR spectroscopy. Science 229:769–772PubMedCrossRefGoogle Scholar
  6. 6.
    Bottomley PA, Herfkens RJ, Smith LS, Bashore TM (1987) Altered phosphate metabolism in myocardial infarction: P-31 spectroscopy. Radiology 165:703–707PubMedGoogle Scholar
  7. 7.
    Bottomley PA, Weiss RG, Hardy CJ, Gerstenblith G (1990) Assessment of myocardial ischemia in patients with coronary artery disease by 31P NMR stress testing: response to therapy. In: Book of Abstracts: Society of Magnetic Resonance in Medicine 1990, vol 1. Berkeley CA, Society of Magnetic Resonance in Medicine, p 244Google Scholar
  8. 8.
    Chance B (1984) Applications of 31P NMR to clinical biochemistry. Ann NY Acad Sci 428:318–331PubMedCrossRefGoogle Scholar
  9. 9.
    Evanochko WT, Bouchard A, Kirklin JK, et al (1990) Detection of cardiac transplant rejection in patients by 31P NMR spectroscopy. In: Book of Abstracts: Society of Magnetic Resonance in Medicine, vol 1. Society of Magnetic Resonance in Medicine, Berkeley CA, p 246Google Scholar
  10. 10.
    Gordon RE, Hanley PE, Shaw D, et al (1980) Localization of metabolites in animals using 31P topical magnetic resonance. Nature 287:737–738Google Scholar
  11. 11.
    Grove TH, Ackerman JJH, Radda GK, Bore PJ (1980) Analysis of rat heart in vivo by phosphorus nuclear magnetic resonance. Proc Natl Acad Sci USA 77:299PubMedCrossRefGoogle Scholar
  12. 12.
    Hardy CJ, Weiss RG, Bottomley PA, Gerstenblith G (1990) Altered cardiac energy status in human cardiomyopathy: correlation with etiology and ejection fraction. In: Book of Abstracts: Society of Magnetic Resonance in Medicine 1990, vol 2. Berkeley CA, Society of Magnetic Resonance in Medicine, p 931Google Scholar
  13. 13.
    Heindel W, Bunke J, Schreier G, et al. (1990) Lokalisierte 31P-NMR Spektroskopie mit ISIS und Oberflächenspule: Methodik und erste Anwendungen bei der Untersuchung von Leber, Transplantatniere und Mediastinum. Fortschr Röntgenstr 152:277–282CrossRefGoogle Scholar
  14. 14.
    Herfkens RJ, Charles HC, Negro-Vilar R, van Trigt P (1988) In vivo phosphorus-31 NMR spectroscopy of human heart transplants. In: Book of Abstracts: Society of Magnetic Resonance in Medicine, vol 2. Berkeley CA, Society of Magnetic Resonance in Medicine, p 827Google Scholar
  15. 15.
    Hoult DI, Busby SJW, Gadian DG, et al (1974) Observation of tissue metabolites using 31P nuclear magnetic resonance. Nature 252:285–287PubMedCrossRefGoogle Scholar
  16. 16.
    Ingwall JS (1982) Phosphorus magnetic resonance spectroscopy of cardiac and skeletal muscles. Am J Physiol 242:H729PubMedGoogle Scholar
  17. 17.
    Kantor HL, Briggs RW, Balaban RS (1984) In vivo 31P nuclear magnetic resonance measurements in canine heart using a catheter-coil. Circ Res 55:261PubMedGoogle Scholar
  18. 18.
    Koretzky AP, Wang S, Murphy-Boesch J, Klein MP, James TL, Weiner MW (1983) 31P NMR spectroscopy of rat organs, in situ, using chronically implanted radiofrequency coils. Proc Natl Acad Sci USA 80:7491CrossRefGoogle Scholar
  19. 19.
    Krahe T, Schindler R, Neubauer S, et al (1991) In vivo-31Phosphor-Myokardspektroskopie: Untersuchungstechnik und erste klinische Ergebnisse. (Vortrag (Work in Progress) beim 4. Internationalen Kernspintomographie Symposium MR’91, Garmisch-Partenkirchen, 22.–27.1.1991)Google Scholar
  20. 20.
    Kreutzer U, Jue T (1990) Measuring intracellular oxygenation in hypoxic and ischemic myocardium in vivo. In: Book of Abstracts: Society of Magnetic Resonance in Medicine, vol 2. Berkeley Ca, Society of Magnetic Resonance in Medicine, p 923Google Scholar
  21. 21.
    Leibfritz D, Offermann W, Kuhn W, et al (1985) P-31 NMR studies on perfused rat organs (heart; diaphragm; gaster) and on human erythrocytes. In: Govil, Khetrapal, Saran (eds) Magnetic resonance in biology and medicine. McGraw-Hill, Neu Delhi, IndienGoogle Scholar
  22. 22.
    Luyten PR, Groen JP, Vermeulen JWAH, den Hollander JA (1989) Experimental approaches to image localized human 31P NMR spectroscopy. Magn Reson Med 11:1–21PubMedCrossRefGoogle Scholar
  23. 23.
    Luyten PR, Bruntink G, Sloff FM, et al (1989) Broadband proton decoupling in human 31P NMR spectroscopy. NMR Biomed 1:177–183PubMedCrossRefGoogle Scholar
  24. 24.
    Mariën AJH, Doornbos J, Roos J de , et al (1990) 1H decoupled 31P NMR spectroscopy of the normal human heart at 1.5 T: a reassessment of metabolite ratios and bulk susceptibility effects. In: Book of Abstracts: Society of Magnetic Resonance in Medicine, vol 1. Berkeley CA, Society of Magnetic Resonance in Medicine, p 249Google Scholar
  25. 25.
    Moon RB, Richards JH (1973) Determination of intracellular pH by 31P magnetic resonance. J Biol Chem 248:7276–7278PubMedGoogle Scholar
  26. 26.
    Neurohr KJ, Gollin G, Barrett EJ, Shulman RG (1983) In vivo 31 P-NMR studies of myocardial high energy phosphate metabolism during anoxia and recovery. FEBS Lett 159:207PubMedCrossRefGoogle Scholar
  27. 27.
    Offermann W, Kuhn W, Soboll S, et al (1987) The in vivo contour plot. An improved representation of stimulus experiments. Magn Reson Med 4:507–516PubMedCrossRefGoogle Scholar
  28. 28.
    Ordidge RJ, Connelly A, Lohmann JAB (1986) Image-selected in vivo spectroscopy (ISIS): a new technique for spatially selective NMR spectroscopy. J Magn Reson 66:283–294Google Scholar
  29. 29.
    Rajagopalan B, Blackledge MJ, McKenna WJ, et al (1987) Measurement of phosphocreatine to ATP ratio in normal and diseased human heart by 31P magnetic resonance spectroscopy using the rotating frame-depth selection technique. Ann NY Acad Sci 508:321–332PubMedCrossRefGoogle Scholar
  30. 30.
    Sakuma H, Takeda K, Yamakado K, et al (1990) P-31 NMR spectroscopy in patients with hypertrophic cardiomyopathy. In: Book of Abstracts: Society of Magnetic Resonance in Medicine, vol 1. Berkeley CA, Society of Magnetic Resonance in Medicine, p 248Google Scholar
  31. 31.
    Schaefer SJ, Gober J, Valenza M, et al (1988) Nuclear magnetic resonance image-guided phos-phorus-31 spectroscopy of the human heart. J Am Coll Cardiol 12:1449PubMedCrossRefGoogle Scholar
  32. 32.
    Schaefer S, Gober JR, Schwartz GG, Twieg DB, Weiner MW, Massy B (1990) In vivo phos-phorus-31 spectroscopic imaging in patients with global myocardial disease. Am J Cardiol 65: 1154–1161PubMedCrossRefGoogle Scholar
  33. 33.
    Shoubridge EA, Jeffrey FMH, Keogh JM, et al (1985) Creatine kinase kinetics, ATP turnover, and cardiac performance in hearts depleted of creatine with the substrate analogue ß-guanidino-propionic acid. Biochim Biophys Acta 874:25–32CrossRefGoogle Scholar
  34. 34.
    Spencer RGS, Baischi JA, Leigh JS, Ingwall JS (1988) ATP synthesis and degradation rates in the perfused rat heart. Biophys J 54:921–929PubMedCrossRefGoogle Scholar
  35. 35.
    Styles P, Scott CA, Radda GK (1985) A method for localizing high resolution NMR spectra from human subjects. Magn Reson Med 2:402–409PubMedCrossRefGoogle Scholar
  36. 36.
    Weiner MW, Hetherington H, Hubesch B, et al (1989) Clinical magnetic resonance spectroscopy of brain, heart, liver, kidney and cancer. A qualitative approach. NMR Biomed 2:290–297PubMedCrossRefGoogle Scholar
  37. 37.
    Whitman GJR, Chance B, Bode H, et al (1985) Diagnosis and therapeutic evaluation of a pediatric case of cardiomyopathy using phosphorus-31 nuclear magnetic resonance spectroscopy. J Am Coll Cardiol 5:745–749PubMedCrossRefGoogle Scholar
  38. 38.
    Wroblewski LC, Aisen AM, Swanson SD, Buda AJ (1990) Evaluation of myocardial viability following ischemic and reperfusion injury using phosphorus 31 nuclear magnetic resonance spectroscopy in vivo. Am Heart J 120/1:31–39PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1991

Authors and Affiliations

  • W. Heindel
  • H. Kugel

There are no affiliations available

Personalised recommendations